|
|
|
![]() We are a company specializing in advanced rapid in vitro immunodiagnostic test systems and electrical bio-sensing system, particularly the blood glucose monitoring system for every day usage.
At TysonBio, we are taking a different approach to the diagnostic of diseases—one focused on developing, acquiring, and commercializing devices to detect and monitor the disease without compromising patient quality of life.
We target development and registration strategies in the United States, Europe, and the rest of the world to facilitate and to obtain regulatory approval in order to assist our partners on accelerating and meeting their health and medical device registration requirements in their perspective countries.
We plan to devote a substantial portion of our efforts to develop glucose monitoring system, and to advance its functions and features to make it more user friendly and meeting the exact needs of diabetics.
We have development capabilities to expand our portfolio of improved versions of currently marketed glucose monitoring system and immunodiagnostic test. In addition, we are actively researching novel medical monitoring devices to compliment our current portfolio within the domain of diabetes management.
Our goal is to build a leading, vertically integrated biomedical manufacturing company with a focused portfolio of proprietary diabetic monitoring system and in vitro immunodiagnostic testing system. With our in-house manufacturing facility and capability covering both the Electromedical and Biochemical devices and reagent, we are uniquely position to serve all of our value partners, and together, striving to provide a safer, more effective diagnostic devices that can make a meaningful difference to millions.
|
| Company: |
Tyson Bioresearch Inc. 台欣生物科技研發股份有限公司 |
Bussiness Type: |
Manufacturer |
| Region: |
Taiwan |
| Capital: |
N/A |
Year Established: |
1999 |
| Verfied: |
|
| Deposit: |
Paid 0.00 US |
| Main Products: |
Glucose．QuikPac Onestep HIV 1/2 Test．QuikPac Onestep HCV Test |
|
